Abstract
Chemogenomic approaches, which link ligand chemistry to bioactivity against targets (and, by extension, to phenotypes) are becoming more and more important due to the increasing number of bioactivity data available both in proprietary databases as well as in the public domain. In this article we review chemogenomics approaches applied in four different domains: Firstly, due to the relationship between protein targets from which an approximate relation between their respective bioactive ligands can be inferred, we investigate the extent to which chemogenomics approaches can be applied to receptor deorphanization. In this case it was found that by using knowledge about active compounds of related proteins, in 93% of all cases enrichment better than random could be obtained. Secondly, we analyze different cheminformatics analysis methods with respect to their behavior in chemogenomics studies, such as subgraph mining and Bayesian models. Thirdly, we illustrate how chemogenomics, in its particular flavor of ‘proteochemometrics’, can be applied to extrapolate bioactivity predictions from given data points to related targets. Finally, we extend the concept of ‘chemogenomics’ approaches, relating ligand chemistry to bioactivity against related targets, into phenotypic space which then falls into the area of ‘chemical genomics’ and ‘chemical genetics’; given that this is very often the desired endpoint of approaches in not only the pharmaceutical industry, but also in academic probe discovery, this is often the endpoint the experimental scientist is most interested in.
Keywords: Chemogenomics, proteochemometrics, deorphanization, GPCR, virtual screening, G-protein coupled receptors, orphan receptors, target prediction, mode of action analysis, bioactivity data, chemical genomics, chemical genetics, academic probe discovery, PubChem Bioassay
Current Topics in Medicinal Chemistry
Title: Chemogenomics Approaches for Receptor Deorphanization and Extensions of the Chemogenomics Concept to Phenotypic Space
Volume: 11 Issue: 15
Author(s): Eelke van der Horst, Julio E. Peironcely, Gerard J. P. van Westen, Olaf O. van den Hoven, Warren R. J. D. Galloway, David R. Spring, Joerg K. Wegner, Herman W. T. van Vlijmen, Ad P. IJzerman, John P. Overington and Andreas Bender
Affiliation:
Keywords: Chemogenomics, proteochemometrics, deorphanization, GPCR, virtual screening, G-protein coupled receptors, orphan receptors, target prediction, mode of action analysis, bioactivity data, chemical genomics, chemical genetics, academic probe discovery, PubChem Bioassay
Abstract: Chemogenomic approaches, which link ligand chemistry to bioactivity against targets (and, by extension, to phenotypes) are becoming more and more important due to the increasing number of bioactivity data available both in proprietary databases as well as in the public domain. In this article we review chemogenomics approaches applied in four different domains: Firstly, due to the relationship between protein targets from which an approximate relation between their respective bioactive ligands can be inferred, we investigate the extent to which chemogenomics approaches can be applied to receptor deorphanization. In this case it was found that by using knowledge about active compounds of related proteins, in 93% of all cases enrichment better than random could be obtained. Secondly, we analyze different cheminformatics analysis methods with respect to their behavior in chemogenomics studies, such as subgraph mining and Bayesian models. Thirdly, we illustrate how chemogenomics, in its particular flavor of ‘proteochemometrics’, can be applied to extrapolate bioactivity predictions from given data points to related targets. Finally, we extend the concept of ‘chemogenomics’ approaches, relating ligand chemistry to bioactivity against related targets, into phenotypic space which then falls into the area of ‘chemical genomics’ and ‘chemical genetics’; given that this is very often the desired endpoint of approaches in not only the pharmaceutical industry, but also in academic probe discovery, this is often the endpoint the experimental scientist is most interested in.
Export Options
About this article
Cite this article as:
van der Horst Eelke, E. Peironcely Julio, J. P. van Westen Gerard, O. van den Hoven Olaf, R. J. D. Galloway Warren, R. Spring David, K. Wegner Joerg, W. T. van Vlijmen Herman, P. IJzerman Ad, P. Overington John and Bender Andreas, Chemogenomics Approaches for Receptor Deorphanization and Extensions of the Chemogenomics Concept to Phenotypic Space, Current Topics in Medicinal Chemistry 2011; 11 (15) . https://dx.doi.org/10.2174/156802611796391230
DOI https://dx.doi.org/10.2174/156802611796391230 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Molecular Biomarkers in Schizophrenia – Implications for Clinical Practice
Current Psychiatry Reviews Detection Method of Environmentally Friendly Non-POP PBDEs by Derivatization-Enhanced Raman Spectroscopy Using the Pharmacophore Model
Current Analytical Chemistry A High Throughput Scintillation Proximity Imaging Assay for Protein Methyltransferases
Combinatorial Chemistry & High Throughput Screening Crystallographic Study and Biological Evaluation of 1,4-dimethyl-<i>N</i>-alkylcarbazoles†
Current Topics in Medicinal Chemistry Indoor Dust Levels of Perfluoroalkyl Substances (PFASs) and the Role of Ingestion as an Exposure Pathway: A Review
Current Organic Chemistry Biomedical Nano Tools: A Potential New Paradigm for Immunoassays and Immune Detection
Current Nanomedicine Can Colorectal Cancer be Prevented or Treated by Oral Hormone Replacement Therapy?
Current Molecular Pharmacology Recent Advances in Chemical Genomics
Current Medicinal Chemistry The Metabolic Fate of Apple Polyphenols in Humans
Current Nutrition & Food Science High Performance Sensors Using Graphene Based Organic-Inorganic Hybrids
Current Organic Chemistry Metabolite Quantification in Tumours by Magnetic Resonance Spectroscopy: Objectives, Results and Perspectives
Current Medical Imaging Synthesis and Biological Evaluation of Sulfonilamidothienopyrimidinone Derivatives as Novel Anti-inflammatory Agents
Medicinal Chemistry Cloning, Characterization and Anti-Inflammatory Properties of <i>Bothrops jararaca</i> Snake Antithrombin
Protein & Peptide Letters Design, Synthesis and Biological Evaluation of Pyrido[2,3-d] Pyrimidine Derivatives as Potential Anticancer Agents
Letters in Drug Design & Discovery The Impact of 5-Substituted Uracil Derivatives on Immortalized Embryo Lung Cells
Letters in Drug Design & Discovery The Molecular Targets of Cannabinoids in the Treatment of Cancer and Inflammation
Current Pharmaceutical Design Review of Cell and Organ Printing Patents
Recent Patents on Biomedical Engineering (Discontinued) COVID-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods
Anti-Cancer Agents in Medicinal Chemistry Characterization of Radiolabeled Dry Powder Leucine, a Constituent of Inhalable Capreomycin
Drug Delivery Letters Recent Trends of Biocompatible and Biodegradable Nanoparticles in Drug Delivery: A Review
Current Medicinal Chemistry